This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Glaukos (GKOS)

Tipranks - Tipranks - Sun Jun 7, 8:44PM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Moderna (MRNA) and Glaukos (GKOS).

Claim 55% Off TipRanks

Moderna (MRNA)

William Blair analyst Myles Minter maintained a Hold rating on Moderna yesterday. The company’s shares closed last Friday at $47.44, close to its 52-week low of $29.25.

According to TipRanks.com, Minter is a 5-star analyst with an average return of 29.8% and a 54.9% success rate. Minter covers the Healthcare sector, focusing on stocks such as Contineum Therapeutics, Inc. Class A, CAMP4 Therapeutics Corporation, and Neumora Therapeutics, Inc. ;'>

Currently, the analyst consensus on Moderna is a Hold with an average price target of $44.61, which is a -12.1% downside from current levels. In a report issued on June 1, Bernstein also maintained a Hold rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

Glaukos (GKOS)

In a report issued on June 5, Allen Gong from J.P. Morgan reiterated a Buy rating on Glaukos. The company’s shares closed last Friday at $125.00.

Gong has an average return of 17.2% when recommending Glaukos. ;'>

According to TipRanks.com, Gong is ranked #3037 out of 12281 analysts.

Currently, the analyst consensus on Glaukos is a Strong Buy with an average price target of $151.56, a 23.6% upside from current levels. In a report issued on May 22, Truist Financial also maintained a Buy rating on the stock.

Read More on MRNA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).